Full-Time

Clinical Program Manager

Oncology

Confirmed live in the last 24 hours

Eikon Therapeutics

Eikon Therapeutics

201-500 employees

Biotech startup developing innovative medicines

AI & Machine Learning
Biotechnology

Compensation Overview

$156.2k - $171.8kAnnually

+ Bonus + Equity Compensation

Mid, Senior

New York, NY, USA + 1 more

More locations: Hayward, CA, USA

Requires onsite presence a minimum of 3 days a week.

Category
Project Management
Business & Strategy
Requirements
  • PhD with 3 years of relevant experience, or a Master’s Degree with 6 years of relevant experience, or a Bachelor’s Degree with 8 years of relevant experience in life sciences, healthcare, or related field preferred.
  • Proficiency in one or more European languages and fluency in English (strong reading, writing, and speaking skills and an ability to effectively communicate with colleagues and stakeholders at all levels) is required.
  • In-depth knowledge of ICH-GCP, EMEA guidelines and other relevant regulations and guidelines.
  • Proficient in using clinical trial management systems (CTMS, RTSM, Veeva Vault suite) and electronic data capture (EDC) systems.
  • Proven ability to manage clinical studies within timelines and budgets while maintaining high quality standards and patient safety.
  • Strong leadership and communication skills, with a demonstrated ability to work collaboratively with cross-functional teams.
  • Experience with management of the budget, resources, headcount, processes and controls, productivity, quality and project delivery.
  • High sense of accountability and urgency in order to prioritize deliverables.
  • Growth mindset and capable of working independently.
  • Ability to work onsite at least 3 days a week.
  • Ideally has PMP certification.
Responsibilities
  • Team leader and builder, who manages trial deliverables, timelines in assigned protocols to meet country commitments and regulatory requirements.
  • Works with minimal oversight from Clinical Operations Senior Director or Director, in collaboration with Clinical Operations teams and Clinical Research and Development functional teams.
  • Ensure that clinical studies are conducted in accordance with approved protocols, ICH-GCP, EMEA, PMDA and other relevant regulations and guidelines.
  • Manage ancillary (non CRO) vendor relationships and performance to ensure that clinical studies are completed in accordance with contract specifications of time, cost and quality ensuring compliance with applicable regulations, guidelines, and company policies.
  • Work with finance, legal, external vendors and clinical sites to ensure the assigned studies are meeting the target milestones.
  • Provide direction to cross-functional study teams to ensure successful study execution.
  • Provide regular updates on study progress to stakeholders (e.g., Clinical Operations, Project & Portfolio Management, Clinical Research).
  • Ensure that all study-related documents are accurate, complete, timely and filed appropriately in all clinical (Veeva TMF), regulatory, safety and finance systems.
  • Oversee and be in compliance with Eikon processes, SOPs, clinical supply and ancillary supplies management, import/export requirements, insurance supply management.
  • Expected to lead, manage, hire global regional Clinical Operations Study Management personnel, as required, to support operational excellence.
  • Contribute to initiatives and projects adding value to Eikon Therapeutics.

Eikon Therapeutics develops new medicines in the pharmaceutical industry by studying biological systems to identify drug targets. They utilize a proprietary single-molecule tracking platform to visualize protein movements in living cells, combined with artificial intelligence and automation for precise molecular interaction analysis. Their diverse team integrates various scientific and engineering disciplines to create therapies aimed at improving the lives of patients with serious diseases. Eikon stands out from competitors by focusing on the dynamic aspects of biology rather than static chemical processes.

Company Stage

Series C

Total Funding

$750.8M

Headquarters

Hayward, California

Founded

2019

Growth & Insights
Headcount

6 month growth

7%

1 year growth

14%

2 year growth

62%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eikon's recent acquisition of global rights to clinical-stage assets and a robust drug development pipeline positions it for significant growth and market impact.
  • The company's strategic partnerships, such as with Impact Therapeutics for PARP1 selective inhibitors, enhance its capabilities in developing targeted cancer therapies.
  • Eikon's expansion into a new 36,284-square-foot office space in Jersey City reflects its growth and commitment to scaling operations.

What critics are saying

  • The highly competitive biotech and pharmaceutical sectors require continuous innovation to maintain a competitive edge.
  • The integration of newly acquired assets and technologies may pose challenges in terms of operational alignment and resource allocation.

What makes Eikon Therapeutics unique

  • Eikon Therapeutics leverages proprietary single-molecule tracking (SMT) technology to visualize protein motion in living cells, setting it apart from competitors who rely on static snapshots of chemical processes.
  • The integration of advanced automation and artificial intelligence allows Eikon to inventory molecular interactions with unprecedented scale and precision.
  • Eikon's diverse team of scientists, engineers, and clinicians enables a multidisciplinary approach to drug development, enhancing innovation and problem-solving capabilities.

Help us improve and share your feedback! Did you find this helpful?